Striverdi Respimat Inhaler Approved for COPD

The FDA has approved Striverdi Respimat (olodaterol; Boehringer Ingelheim) inhalation spray for the treatment of patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema with airflow obstruction.

Do E-Cigarette Benefits Outweigh the Harms?

Allowing e-cigarettes to compete with regular cigarettes might cut tobacco-related deaths and illness, according to a new study.

Increasing Malarial Drug Resistance a Growing Threat

The parasite that causes malaria is growing increasingly resistant to the drugs commonly used to fight it, according to new surveillance reports.

Polymyalgia Rheumatica Carries Higher Vascular Event Risk

A new study has found that polymyalgia rheumatica is associated with an increased risk of vascular events

Pain, Itch May Be Skin Cancer Indicators

The presence and intensity of pain and itch may be indicators of skin cancer.

Depression Independent Risk Factor for Dementia, Study Suggests

For older adults, depressive symptoms are associated with cognitive decline but appear independent of the neuropathologic hallmarks of dementia.